Hermetica Superfood Encyclopedia
The Short Answer
Biochanin A is an isoflavonoid compound found in red clover that acts as a selective estrogen receptor modulator and phytoestrogen. It demonstrates potential anticancer and neuroprotective effects through estrogen receptor binding and Sirt1 pathway activation.
CategoryNamed Bioactive Compounds
GroupCompound
Evidence LevelStrong
Primary Keywordbiochanin A benefits
Synergy Pairings3
Biochanin A — botanical close-up
Health Benefits
Origin & History
Natural habitat
Biochanin A is an isoflavone, a subclass of flavonoids within the polyphenol family, primarily extracted from red clover (Trifolium pratense) with additional sources in soy and other legumes. Extraction typically involves solvent-based methods from plant materials, and it is commercially available as a dietary supplement.
“No specific historical or traditional medicine uses in systems like Ayurveda or TCM are documented in the available research. The compound is noted in red clover contexts for potential health maintenance, but without specific traditional timelines or systems specified.”Traditional Medicine
Scientific Research
No human clinical trials, RCTs, or meta-analyses have been conducted on Biochanin A to date. All available evidence comes from preclinical studies including in vitro cell culture experiments and in vivo animal models, with researchers explicitly noting the need for human trials to establish safety and efficacy.
Preparation & Dosage
Traditional preparation
No clinically studied dosage ranges are available due to lack of human trials. Preclinical studies used varying concentrations: 0.5-100 μM in cell cultures and 10-65 mg/kg in animal models. Consult a healthcare provider before starting any new supplement.
Nutritional Profile
Biochanin A is a pure isoflavone compound (4-methylglenistin), not a whole food, so traditional macronutrient/micronutrient profiling does not apply. Molecular weight: 284.26 g/mol. Chemical formula: C16H12O5. It is a methylated isoflavone (O-methylated form of genistein) found naturally in red clover (Trifolium pratense) at approximately 1–5 mg/g dry weight, chickpeas (Cicer arietinum) at 0.1–0.5 mg/g, and fenugreek seeds at trace levels. Bioactive classification: phytoestrogen, polyphenol, isoflavone subclass. Estrogenic activity: weak estrogen receptor agonist (ERα and ERβ), with relative binding affinity approximately 100–1000-fold lower than 17β-estradiol. Bioavailability: oral bioavailability is limited (~10–20% estimated in animal models) due to extensive first-pass metabolism; Biochanin A is partially demethylated to genistein by intestinal microbiota and liver enzymes (CYP1A2, CYP3A4), which may enhance or alter its biological activity. Peak plasma concentration following 40 mg oral dose in humans estimated at 0.5–1.5 μM. Half-life approximately 5–8 hours. Lipophilicity (LogP ≈ 2.8) suggests moderate membrane permeability. No fiber, protein, fat, or micronutrient content is applicable as this is an isolated bioactive compound. Preclinical effective concentrations range from 10–100 μM in cell-based assays, which substantially exceeds physiologically achievable plasma concentrations from dietary sources alone.
How It Works
Mechanism of Action
Biochanin A functions as a selective estrogen receptor modulator, binding to both ERα and ERβ receptors with preferential affinity for ERβ. It activates the Sirt1 (sirtuin 1) pathway, promoting cellular longevity and neuroprotection. The compound also modulates apoptotic pathways and inhibits tumor cell proliferation through p53-mediated mechanisms.
Clinical Evidence
Current evidence for biochanin A comes primarily from preclinical studies, with no completed human clinical trials. In vitro studies show anticancer effects against prostate, lung, and colon cancer cell lines at concentrations of 10-100 μM. Animal studies demonstrate neuroprotective properties in Parkinson's disease models through Sirt1 activation. Human research is needed to establish clinical efficacy and optimal dosing protocols.
Safety & Interactions
Biochanin A appears well-tolerated in preclinical studies, but human safety data is limited. As a phytoestrogen, it may interact with hormone-sensitive medications and conditions including breast cancer, endometriosis, and uterine fibroids. Potential interactions with anticoagulant medications due to structural similarity to other isoflavonoids. Pregnant and breastfeeding women should avoid supplementation due to unknown effects on fetal development.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
5,7-dihydroxy-4'-methoxyisoflavoneBCA4'-O-methylgenisteinRed clover isoflavoneBiochanin-A5,7-dihydroxy-3-(4-methoxyphenyl)-4H-chromen-4-one
Frequently Asked Questions
What foods contain biochanin A naturally?
Red clover is the primary natural source of biochanin A, containing 0.1-2.5% by dry weight. Smaller amounts are found in chickpeas, alfalfa sprouts, and some legumes.
What is the recommended dosage of biochanin A?
No established human dosage exists due to lack of clinical trials. Preclinical studies used concentrations of 10-100 μM, but human equivalent doses have not been determined.
How long does biochanin A take to show effects?
In laboratory studies, cellular effects occurred within 24-72 hours of treatment. Human timeframes are unknown due to absence of clinical trials.
Can biochanin A interact with birth control pills?
As a phytoestrogen, biochanin A may theoretically interact with hormonal contraceptives by competing for estrogen receptors. Consult healthcare providers before combining with hormonal medications.
Is biochanin A the same as genistein?
No, biochanin A and genistein are different isoflavonoids with distinct molecular structures. Biochanin A is a methylated precursor that can be converted to genistein in the body.
What does current clinical research show about biochanin A's effectiveness in humans?
Most evidence for biochanin A comes from preclinical studies in cell cultures and animal models, particularly for anticancer and neuroprotective effects. While these studies show promise in prostate, lung, and colon cancer cell lines and Parkinson's disease models, human clinical trials are limited and further research is needed to confirm safety and efficacy in people. Current evidence is insufficient to make definitive claims about clinical benefits in humans.
Who should avoid taking biochanin A supplements?
Pregnant and nursing women should consult a healthcare provider before using biochanin A, as safety data in these populations is limited. Individuals taking hormone-sensitive medications, estrogen-based therapies, or those with a history of hormone-sensitive cancers should discuss supplementation with their doctor due to biochanin A's estrogenic activity. People with bleeding disorders or taking anticoagulants should also seek medical guidance before supplementing.
What is the difference between biochanin A and other isoflavones like daidzein?
Biochanin A is a methylated isoflavone found primarily in red clover and alfalfa, while daidzein is a non-methylated isoflavone common in soy and other legumes. The methylation structure of biochanin A may affect its bioavailability and metabolism differently than daidzein, and biochanin A must be converted to daidzein by gut bacteria for some biological activity. Both share estrogenic properties but differ in food sources, chemical structure, and research applications.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w biochanin-a curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
